Status:
COMPLETED
Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
Lead Sponsor:
Medivir
Conditions:
Herpes Labialis
Eligibility:
All Genders
12-17 years
Phase:
PHASE3
Brief Summary
The Purpose of this study is to evaluate the safety of ME-609 for the treatment of recurrent herpes labialis in adolescents.
Detailed Description
The objective of the study was to evaluate the safety of ME-609 for the treatment of herpes labialis recurrences in immunocompetent adolescents, 12 - 17 years of age, following a 5-day treatment with ...
Eligibility Criteria
Inclusion
- General good health
- History of recurrent herpes labialis with at two recurrences during the last twelve months
Exclusion
- Treatment with systemic or topical antiviral agents or steroids within two weeks prior to inclusion
- Significant skin condition that occur in the area of herpes recurrences
- Nursing or/and pregnancy
- Immunosupressed state due to underlying disease (e.g. HIV infection or concomitant treatment (e.g. cancer chemotherapy)
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
254 Patients enrolled
Trial Details
Trial ID
NCT00375570
Start Date
October 1 2006
End Date
September 1 2007
Last Update
August 18 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.